mirecule logo.png
miRecule Inc. closes $5.7 M to Create Breakthrough RNA Therapies for Cancer and Muscular Dystrophy
May 27, 2021 11:07 ET | miRecule
GAITHERSBURG, Md., May 27, 2021 (GLOBE NEWSWIRE) -- miRecule, Inc. (“miRecule”), an emerging biotech company focused on the development of cutting-edge RNA therapeutics, announced today it has...
AskBio Launches AskFirst™ Patient Advocacy Program to Educate and Support Participants in Gene Therapy Clinical Trials
January 29, 2020 10:27 ET | Asklepios BioPharmaceutical, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a clinical-stage adeno-associated virus (AAV) gene therapy company, today introduced...
Going the Distance for Duchenne
July 09, 2019 15:34 ET | Jett Foundation
Plymouth, MA, July 09, 2019 (GLOBE NEWSWIRE) -- A group of inspiring young people will join Jett Foundation, a non-profit organization dedicated to awareness and helping fight Duchenne muscular...
MDA Awards $300,000 to Streamline Gathering of Data for ALS Research
June 15, 2017 16:24 ET | Muscular Dystrophy Association
Chicago, June 15, 2017 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association has announced the award of a clinical research network grant (CRNG) to Michael Benatar, M.D., Ph.D., at the University...
Gala Logo.jpg
Gala Global to Finalize Initial Hemp "CBD" Products
February 11, 2015 08:00 ET | Gala Pharmaceutical Inc.
LOS ANGELES, Feb. 11, 2015 (GLOBE NEWSWIRE) -- Gala Global, Inc. (OTCQB:GLAG) today announced it has finalized the initial CBD products. The initial products will based on flavored infused CBD Oral...
Prosensa Holding B.V. Logo
Prosensa announces Lancet Neurology publication of an exploratory phase II study (DEMAND II) demonstrating efficacy and safety of drisapersen in patients with Duchenne muscular dystrophy
September 08, 2014 08:00 ET | Prosensa Holding N.V.
Leiden, The Netherlands, Sept. 8, 2014 (GLOBE NEWSWIRE) -- LEIDEN, The Netherlands - September 8, 2014 - Prosensa Holding N.V. (NASDAQ: RNA), the biopharmaceutical company focusing on RNA-modulating...
Prosensa Holding B.V. Logo
Prosensa Completes Enrollment in Natural History Study of Duchenne Muscular Dystrophy
June 25, 2014 08:00 ET | Prosensa Holding N.V.
Leiden, The Netherlands, June 25, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high...
Prosensa Holding B.V. Logo
Prosensa Holding N.V. to Webcast Conference Call Discussing 1st Quarter 2014 Financial Results and Corporate Update on May 20, 2014
May 13, 2014 08:57 ET | Prosensa Holding N.V.
Leiden, The Netherlands, May 13, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced that the Company will host a conference call and live audio webcast on Tuesday, May 20,...
The Dussin Group's Old Spaghetti Factory "Shamrocks Against Dystrophy" Campaign Raises Record $100,000 Nationwide for Muscular Dystrophy Association PORTLAND, OR--(Marketwire - Apr 13, 2011) - The Dussin Group's Old Spaghetti Factory restaurant chain continues to shine as champion for families living with progressive muscle diseases in Arizona,...